Login

The Investor on Tour - Q&A with Francis Van Eeckhout, CEO Deceuninck | Francis Van Eeckhout - CEO of Deceuninck 00:10:00

Share On Facebook Share On Twitter

Francis Van Eeckhout is Chairman/Interim CEO at Deceuninck.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Sal Khan's Vision for Education: From Hedge Fund Analyst to Founder of Khan Academy|Sal Khan
00:10:00
Understanding Financial Planning and the Gap Analysis Process
00:10:00
Erik Carlson, Dish Network Corp. CEO, comments on Comcast Corp.'s successful bid for Sky Plc in a discussion about the evolving landscape of the telecommunications industry.|Hamid Akhavan is the President and CEO of DISH and EchoStar
00:10:00
Orea Mining CEO, Rock Lefrançois, Unveils Corporate Update and Expansion Plans at Toronto Metals Investment Forum | Rock Lefrançois - CEO of Oreo Mining
00:10:00
Demystifying Finance Industry Designations: CFP®, CFA, and CPA Explained | Elizabeth Hutton - VICE PRESIDENT, FINANCIAL PLANNER of Howe & Rusling, Inc.
00:00:00
Maha Farhat, MD, MSc Gilbert S. Omenn Associate Professor of Biomedical Informatics, HMS| DNA of Bacteria and Antibiotic Resistance
00:10:00
Russian Banking Outlook Amidst Economic Challenges and Geopolitical Tensions | Andrey Kostin, CEO , VTB Bank .
00:10:00
Employee 1st Impact: Insights from H&E Equipment Services CEO | Bradley W. Barber - Chief Executive Officer and Director of H&E Equipment Services, Inc.
00:10:00
focused on identifying opportunities where technology will disrupt traditional|Austin McChord,Managing Partner,Outsiders Fund
00:10:00
JB Hi-Fi's Strong Quarterly Growth and Resilient Performance Despite Economic Uncertainty
00:10:00
Gary Harris on Navigating Market Cycles and Client-Centric Investment Strategies
00:10:00
Interview with Brian Cox, SurgePays CEO, regarding $SURG.|Kevin Brian Cox. Chairman/CEO, SurgePays Inc ;

© 2026 Nehu